🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Standard Chemical & Pharmaceutical Co., Ltd. (TPE:1720)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
53.00
-1.50 (-2.75%)
Nov 20, 2026, 1:30 PM CST

TPE:1720 Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
7,2307,0236,7896,2405,8514,604
Revenue Growth
4.62%3.44%8.81%6.64%27.09%6.94%
Cost of Revenue
4,0724,1143,8013,5143,3642,536
Gross Profit
3,1582,9092,9892,7252,4882,068
Selling, General & Admin
1,3011,2881,2931,2091,100948.47
Research & Development
271.25260.36288.09266.27251.88241.79
Operating Expenses
1,5721,5461,5921,4661,3691,191
Operating Income
1,5861,3631,3971,2601,118876.83
Interest Expense
-9.34-8.45-15.07-25.42-18.78-7.25
Interest & Investment Income
43.53122.5250.4876.8439.4524.99
Earnings From Equity Investments
-20.24-4.66-11.3641.5661.37-6.16
Currency Exchange Gain (Loss)
51.31-15.5786.855.62170.44-25.6
Other Non Operating Income (Expenses)
30.7742.9751.0830.135.4477.66
EBT Excluding Unusual Items
1,6821,5001,5581,3881,406940.47
Gain (Loss) on Sale of Investments
32.6315.73-0.675.531.361.46
Gain (Loss) on Sale of Assets
-3.33-1.09-5.471.27-7.7873.78
Asset Writedown
-0.4-0.4----1.81
Other Unusual Items
0.120.01-0.190.020.11-66.45
Pretax Income
1,7111,5141,6271,4381,4001,014
Income Tax Expense
334.22258.35333.05279.94246.31176.95
Earnings From Continuing Operations
1,3771,2561,2941,1581,154836.8
Minority Interest in Earnings
-375.08-327.87-413.81-323.04-338.21-130.07
Net Income
1,002927.66880.5834.89815.41706.73
Net Income to Common
1,002927.66880.5834.89815.41706.73
Net Income Growth
12.20%5.36%5.46%2.39%15.38%34.83%
Shares Outstanding (Basic)
197197197197197197
Shares Outstanding (Diluted)
197197197197197197
Shares Change
0.02%0.01%0.01%0.00%-0.02%0.02%
EPS (Basic)
5.104.724.484.254.153.60
EPS (Diluted)
5.094.714.474.254.153.59
EPS Growth
12.07%5.29%5.35%2.41%15.45%34.81%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1,2521,2741,098710.8331.78613.56
Free Cash Flow Per Share
6.366.475.583.610.163.12
Dividend Per Share
1.8181.8182.5462.4542.2732.273
Dividend Growth
-28.57%-28.57%3.71%8.00%0%38.88%
Gross Margin
43.68%41.42%44.02%43.68%42.51%44.91%
Operating Margin
21.94%19.41%20.57%20.19%19.11%19.05%
Profit Margin
13.86%13.21%12.97%13.38%13.94%15.35%
Free Cash Flow Margin
17.31%18.14%16.18%11.39%0.54%13.33%
EBITDA
1,9921,7651,7721,5791,3891,073
EBITDA Margin
27.55%25.13%26.09%25.30%23.74%23.31%
D&A For EBITDA
405.47402.18375.06319.44270.67196.31
EBIT
1,5861,3631,3971,2601,118876.83
EBIT Margin
21.94%19.41%20.57%20.19%19.11%19.05%
Effective Tax Rate
19.53%17.07%20.47%19.47%17.59%17.46%